3 tracked superinvestors hold BRISTOL-MYERS SQUIBB CO (BMY), worth $1.6B combined, led by PRIMECAP team. Smart money is holding BMY as of the latest 13F filings.
Current price
$57.94
+24.4%
1Y
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in…
Market cap
$118.9B
P/E
16.31
Div yield
4.3%
Revenue YoY
-0.2%
Analyst target
$63
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
3
tracked 13F / N-PORT funds
Combined value
$1.6B
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
0
1 buying · 1 selling
Smart money is holding BMY steady this quarter — buys and sells are balanced.
BRISTOL-MYERS SQUIBB CO (BMY) is held by 3 tracked funds worth $1.6B combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to PRIMECAP team at 1.4% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 1 added and 1 trimmed, a net add.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 1.4% | $867M | |
| Added | 0.6% | $703M | |
| Trimmed | 1.1% | $4M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own BMY?
3 tracked funds hold BRISTOL-MYERS SQUIBB CO (BMY), the largest being PRIMECAP team (Vanguard PRIMECAP) at 1.4% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling BMY?
In the most recent 13F quarter, 1 tracked fund added or opened BMY and 1 trimmed it.
How much BMY do tracked funds hold?
Combined disclosed long exposure to BMY across tracked superinvestors is $1.6B as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.